echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Biotechnology News > Twist Bioscience is now selling a synthetic RNA positive control for the new crown mutant strain Omi Keron (B.1.1.529/BA.1) in order to develop accurate diagnostic tests

    Twist Bioscience is now selling a synthetic RNA positive control for the new crown mutant strain Omi Keron (B.1.1.529/BA.1) in order to develop accurate diagnostic tests

    • Last Update: 2021-12-24
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    South San Francisco, California, USA--(Business Wire)--December 15, 2021--Twist Bioscience (NASDAQ: TWST) is a company that uses its silicon-based platform to provide high-quality synthetic DNA to help customers obtain A successful company, the company today announced the launch of a synthetic RNA positive control for the SARS-CoV-2 mutant strain Omi Keron (B.


    Dr.


    Dr.


    To learn more about the products provided by Twist in the fight against COVID-19, including a full set of NGS test panels (panel) that track the emergence of new SARS-CoV-2 strains, please visit https:// research-tools


    In March 2020, Twist first launched different SARS-CoV-2 synthetic RNA reference sequences, and is developing next-generation sequencing (NGS) and reverse transcription polymerase chain reaction (RT-PCR) for SARS-CoV-2 detection.


    The Twist synthetic control is designed based on a specific SARS-CoV-2 variant, covering the complete viral genome, and the sequence has been verified


    Customers who purchase synthetic controls must comply with the biosafety inspection protocol led by Twist and applicable laws and regulations


    About Twist Bioscience

    Twist Bioscience is a leading and fast-growing synthetic biology and genomics company that has developed a disruptive DNA synthesis platform to promote the industrialization of bioengineering


    Legal statement regarding forward-looking statements

    This press release contains forward-looking statements



    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.